Abstract

High circulating nonesterified fatty acids (NEFAs) concentration, often reported in diabetes, leads to impaired glucose-stimulated insulin secretion (GSIS) through not yet well-defined mechanisms. Serotonin and dopamine might contribute to NEFA-dependent β-cell dysfunction, since extracellular signal of these monoamines decreases GSIS. Moreover, palmitate-treated β-cells may enhance the expression of the serotonin receptor Htr2c, affecting insulin secretion. Additionally, the expression of monoamine-oxidase type B (Maob) seems to be lower in islets from humans and mice with diabetes compared to nondiabetic islets, which may lead to increased monoamine concentrations. We assessed the expression of serotonin- and dopamine-related genes in islets from db/db and wild-type (WT) mice. In addition, the effect of palmitate and oleate on the expression of such genes, 5HT content, and GSIS in MIN6 β-cell was determined. Lower Maob expression was found in islets from db/db versus WT mice and in MIN6 β-cells in response to palmitate and oleate treatment compared to vehicle. Reduced 5HT content and impaired GSIS in response to palmitate (−25%; p < 0.0001) and oleate (−43%; p < 0.0001) were detected in MIN6 β-cells. In conclusion, known defects of GSIS in islets from db/db mice and MIN6 β-cells treated with NEFAs are accompanied by reduced Maob expression and reduced 5HT content.

Highlights

  • Both insulin resistance and β-cell failure are involved in the etiology of type-2 diabetes (DM2) phenotype [1]

  • It is known that db/db mice islets have functional defects and increased compensatory β-cell mass [40,41,42]; in agreement we observed a higher size in islets from db/db compared to WT mice

  • We have shown that islets from WT and db/db mice expressed mRNAs of most genes related to the serotonin and dopamine metabolism, including enzymes involved in the synthesis (Tph1/2, Tyrosine hydroxylase (TH), and Ddc), vesicular transport (Slc18a1/2-VMAT1/2), and degradation (Maoa, monoamine-oxidase type B (Maob), and Comt) of these monoamines

Read more

Summary

Introduction

Both insulin resistance and β-cell failure are involved in the etiology of type-2 diabetes (DM2) phenotype [1]. Lipid infusion in nondiabetic subjects leading to circulating NEFAs levels similar to those found in diabetic people (500–800 μM) decreased glucose-stimulated insulin secretion (GSIS) [7]. Several in vitro studies have demonstrated that long-term exposure of β-cells lines and murine islets to palmitic (C16:0) and oleic (C18:1) acids leads to impaired GSIS [5, 8,9,10]. Other studies have explained impaired GSIS as a consequence of excessive production of radical oxygen species (ROS), which is dependent on mitochondrial fatty acid metabolism [9]. These mechanisms do not fully explain such decreased GSIS, and alternative mechanisms may be taking place

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call